Violetta Cotreau
Keine laufenden Positionen mehr
Karriereverlauf von Violetta Cotreau
Ehemalige bekannte Positionen von Violetta Cotreau
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01.12.2020 | 30.12.2022 |
| Corporate Officer/Principal | 30.12.2022 | 30.12.2022 | |
| AMAG PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.12.2016 | 01.11.2020 |
Ausbildung von Violetta Cotreau
| University of Massachusetts Lowell | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Comptroller/Controller/Auditor | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Violetta Cotreau
- Erfahrung
